MENU
IGMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
IGM Biosciences (IGMS) Ownership - Who owns IGM Biosciences?
Profile
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
863.68M
P/E Ratio
N/A
Total Cash
256.38M
Projected Growth
N/A
Total Debt
39.37M
Revenue
2.91M
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash/Share
4.32
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
IGMS
Capitalization
864M
P/E Ratio
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash
256M
Total Cash/Share
4.32
Total Debt
39.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
2.91M
ROE
N/A
Book Value
122M
P/B Ratio
6.97
Cash Flow
N/A
Earnings
-3.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
592K
Current Ratio
7.06
Current Revenue Per Employee
6147.06
Dividends Per Share - Security
N/A
EBITDA
-228.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-53.94
Shares Held By Institutions
264M
Shares Outstanding - Current
59.3M
Total Liabilities
214M
Total Volume MTD
N/A
Value
-1
Gain YTD
72.924
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company, which develops antibodies for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com